LCA5L anticorps (N-Term)

N° du produit ABIN631770

Cet anticorps anti-LCA5L est un anticorps Lapin Polyclonal détectant LCA5L dans WB. Adapté pour Humain.

Aperçu rapide pour LCA5L anticorps (N-Term) (ABIN631770)

Antigène: LCA5L (Leber Congenital Amaurosis 5-Like (LCA5L))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp LCA5L est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-LCA5L anticorps

Épitope: N-Term

Specificité: C21 ORF13 antibody was raised against the N terminal Of C21 rf13

Purification: Affinity purified

Immunogène: C21 ORF13 antibody was raised using the N terminal Of C21 rf13 corresponding to a region with amino acids SLADLTKTNIDEHFFGVALENNRRSAACKRSPGTGDFSRNSNASNKSVDY

Information d'application

Indications d'application: WB: 1 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

C21ORF13 Blocking Peptide, (ABIN5612486), is also available for use as a blocking control in assays to test for specificity of this C21ORF13 antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of C20 RF13 antibody in PBS

Concentration: Lot specific

Buffer: PBS

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Détails sur LCA5L

Antigène: LCA5L (Leber Congenital Amaurosis 5-Like (LCA5L))

Autre désignation: C21ORF13

Sujet: The function of the C21orf13 protein has not been widely studied, and is yet to be fully elucidated.

Poids moléculaire: 76 kDa (MW of target protein)